UDP Glucuronide—Drug Metabolism and Biosynthesis (CAS No.: 2616-64-0)

UDP glucuronic acid is one of the indispensable sugar nucleotides in cells and is known as the "bridge molecule for drug metabolism". It is not only the core coenzyme of glucuronidation reaction in organisms, but also an important raw material in the fields of modern drug development, metabolic engineering and disease treatment. From drug detoxification to polysaccharide synthesis, UDP glucuronic acid is driving a wave of innovation in precision medicine and biopharmaceuticals.

Chemical Information

· Chemical name: Uridine-5'-diphosphate glucuronide

· Common name: UDP glucuronic acid

· Chemical formula: C15H22N2O18P2

· Molecular weight: 580.29 g/mol

· CAS number: 2616-64-0

Structural features

UDP glucuronic acid is composed of uridine diphosphate (UDP) and glucuronic acid connected through a pyrophosphate bond. Its unique features are:

· High-energy pyrophosphate bond: The UDP part is connected to glucuronic acid through a pyrophosphate bond. This structure makes it an "activated" glucuronic acid donor, which can efficiently participate in enzymatic reactions and release energy to drive biosynthesis.

· Multifunctional functional group: The glucuronic acid unit contains a carboxyl group, which makes it negatively charged under physiological conditions, enhances water solubility and reactivity, and facilitates the formation of stable glucuronide conjugates with substrates (such as drug molecules).

· Biocompatibility: As an endogenous molecule, UDP glucuronic acid has good biocompatibility and can be seamlessly integrated into cellular metabolic pathways to reduce the risk of exogenous toxicity.

Main applications and advantages

1. Core coenzymes for drug metabolism and detoxification

o Enhance drug clearance: In the liver and intestines, UDP glucuronic acid is the key substrate for the glucuronidation reaction. Hydrophobic drugs, toxins or endogenous compounds (such as bilirubin) are converted into water-soluble glucuronides through UGT enzymes, which greatly improves renal excretion efficiency and reduces drug toxicity and side effects.

o Optimize pharmacokinetics: This process is the main pathway of phase II metabolism of drugs and helps to improve the half-life and bioavailability of drugs. In drug development, using UDP glucuronide as a tool can assess the metabolic stability of candidate compounds and accelerate preclinical studies.

2. Important raw materials for biosynthesis and tissue engineering

o Glycosaminoglycan synthesis: UDP glucuronic acid is the precursor of glycosaminoglycans such as hyaluronic acid and chondroitin sulfate. These molecules are essential for extracellular matrix structure, joint lubrication and tissue repair. In tissue engineering and regenerative medicine, it can be used to synthesize biomaterials and promote wound healing and cartilage regeneration.

o Cell signaling regulation: By participating in polysaccharide synthesis, UDP glucuronic acid indirectly affects cell adhesion, differentiation and immune response, providing new ideas for cancer treatment (such as targeting the tumor microenvironment).

3. Basic research and development of diagnostic tools

o Enzyme research tools: As the standard substrate of UGT enzyme, UDP glucuronic acid is an ideal reagent for studying drug metabolism mechanism, enzyme kinetics and genetic polymorphism, helping to reveal the molecular basis of personalized medicine.

o Disease biomarkers: In some metabolic diseases (such as Gilbert syndrome) or liver dysfunction, UDP glucuronide levels or related enzyme activities are abnormal, making them potential diagnostic indicators.

Conclusion

UDP glucuronic acid is not only a metabolic intermediate, but also a key hub connecting drug development and human health. From drug detoxification to tissue regeneration, from metabolic research to personalized medicine, its application prospects are broad